Oral med for obesity, stem cells after heart failure, blood markers and MS, and predicting atherosclerosis
Update: 2025-11-07
1
Description
Program notes:
0:37 An oral med for obesity
1:37 Five to 10% stopped medication
2:35 Need head-to-head trials with injectable
3:00 Stem cell infusion after MI and heart failure
4:01 Reduced heart failure in recipients
5:01 Twice as many in the control arm
6:01 Moving past BMI in predicting atherosclerosis
7:01 Especially in overweight but not obese
8:01 Almost 3000 participants in Brazil
8:25 Blood samples precede MS
9:04 Seen seven years beforehand
10:02 Twin studies and relatives
11:03 Way to intervene earlier
11:15 Applaud OpenAI
13:00 End
Comments
In Channel




